>
Switch to:

Turning Point Therapeutics Capex-to-Revenue

: 0.00 (As of Dec. 2020)
View and export this data going back to 2019. Start your Free Trial

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Turning Point Therapeutics's Capital Expenditure for the three months ended in Dec. 2020 was $-0.39 Mil. Its Revenue for the three months ended in Dec. 2020 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Turning Point Therapeutics Capex-to-Revenue Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Capex-to-Revenue - - - 0.05

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Capex-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 -

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics Capex-to-Revenue Distribution

* The bar in red indicates where Turning Point Therapeutics's Capex-to-Revenue falls into.



Turning Point Therapeutics Capex-to-Revenue Calculation

Turning Point Therapeutics's Capex-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.264) / 25
=0.05

Turning Point Therapeutics's Capex-to-Revenue for the quarter that ended in Dec. 2020 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.39) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics  (NAS:TPTX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Rvenue Raio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Turning Point Therapeutics Capex-to-Revenue Related Terms


Turning Point Therapeutics Capex-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)